| Scott Alan Schlidt, MD | |
|
2315 N Lake Dr, 703, Milwaukee, WI 53211-4518 | |
| (414) 271-5119 | |
| (414) 271-3756 |
| Full Name | Scott Alan Schlidt |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 30 Years |
| Location | 2315 N Lake Dr, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063463719 | NPI | - | NPPES |
| 34564800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 47220 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer - cancer found on the descending section of the colon, where faeces is stored.
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
› Verified 5 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer - cancer found on the descending section of the colon, where faeces is stored.
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
› Verified 5 days ago
| Entity Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer - cancer found on the descending section of the colon, where faeces is stored.
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
› Verified 5 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer - cancer found on the descending section of the colon, where faeces is stored.
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Alan Schlidt, MD 2315 N Lake Dr, 703, Milwaukee, WI 53211-4518 Ph: (414) 271-5119 | Scott Alan Schlidt, MD 2315 N Lake Dr, 703, Milwaukee, WI 53211-4518 Ph: (414) 271-5119 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.
When comparing the effects of red meat, poultry, fish or vegetarian diets to cancer development in specific subsites of the colon, a study found that those regularly eating red meat compared to a red meat-free diet had higher rates of distal colon cancer - cancer found on the descending section of the colon, where faeces is stored.
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
› Verified 5 days ago
Dr. Viktor Hraska, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Suite 3510, Milwaukee, WI 53226 Phone: 414-805-5701 | |
H Adam Ubert, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6900 Fax: 414-955-0079 | |
Mario G Gasparri, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6000 | |
John F Just, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3333 N Mayfair Rd, Suite 209, Milwaukee, WI 53222 Phone: 414-258-0670 Fax: 414-238-2398 | |
Leonard H Kleinman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2901 W Kinnickinnic River Pkwy, #310, Milwaukee, WI 53215 Phone: 414-649-3990 Fax: 414-649-3969 | |
Dr. Hossein Almassi, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Cardiothoracic Surgery, Milwaukee, WI 53226 Phone: 414-955-6900 Fax: 414-955-6204 |